Intravascular Ultrasound Market - Global Forecast 2025-2032

Senior healthcare leaders navigating the intravascular ultrasound (IVUS) market are experiencing rapid transformation, as advancing medical imaging technologies and evolving clinical protocols redefine standards in cardiovascular care and operational decision-making.

Market Snapshot: Intravascular Ultrasound Growth Trajectory

The intravascular ultrasound market is progressing steadily, driven by rising incidences of cardiovascular disease and technological improvements in image-guided therapy. Market valuation is forecasted to increase from USD 910.95 million in 2024 to USD 959.20 million in 2025, with a compound annual growth rate (CAGR) of 5.33%. Projections extend to USD 1.38 billion by 2032. Healthcare providers globally, including hospitals, clinics, and research institutes in both mature and emerging economies, are adopting IVUS to enhance clinical outcomes and align with tightening regulatory expectations. Supplier strategies now focus on delivering platforms that support precision imaging and minimally invasive procedures, ensuring compatibility with varied healthcare delivery settings.

Scope & Segmentation of the Intravascular Ultrasound Market

This analysis delineates a practical segmentation model for business planning and competitive benchmarking in the IVUS sector. Understanding each segment’s role empowers executive decision-making and strategic focus:

• Applications: Encompasses coronary artery imaging for acute and chronic vascular conditions, peripheral interventions, and the management of diverse vascular pathologies—enabling comprehensive patient assessments.
• Device Types: Includes catheter-based IVUS solutions (array and single element designs) and imaging consoles, portable or stationary, which support a wide array of hospital, ambulatory, and research infrastructure demands.
• End Use: Refers to adoption within hospitals, ambulatory surgical centers, and research organizations, each requiring specific workflow integration and clinical compatibility.
• Procedures: Covers diagnostic and therapeutic interventions, such as vascular imaging for plaque characterization and support for atherectomy or stenting, driving robust procedural outcomes and patient safety.
• Regions: Provides focused analysis for the Americas (including the United States, Canada, Mexico, Brazil, Argentina, Chile, Colombia, Peru), Europe, Middle East and Africa (United Kingdom, Germany, France, Russia, Italy, Spain, among others), and Asia-Pacific (notably China, India, Japan, Australia, South Korea), highlighting localized adoption and regulatory considerations.
• Key Companies: Features profiles and strategies of main players such as Koninklijke Philips N.V., Boston Scientific Corporation, Siemens Healthineers AG, General Electric Company, Abbott Laboratories, Canon Medical Systems Corporation, Terumo Corporation, ACIST Medical Systems, Inc., and InfraReDx, Inc.

Key Takeaways for Senior Decision-Makers

• Advancements in high-frequency ultrasound transducers and machine learning integration are broadening IVUS utility, increasing the ability to customize procedures for individual patient needs and specific clinical situations.
• IVUS use is expanding within peripheral vascular disease management, enabling healthcare systems to address a broader spectrum of patient requirements through augmented procedural portfolios.
• Integration with secure digital solutions, such as cloud-enabled analytics and real-time data transfer, is enhancing clinical workflows and supporting improved collaborative care across departments.
• Procurement approaches are shifting toward modular equipment, bundled service packages, and scalable purchasing options, supporting operational flexibility under constrained budgets.
• Collaboration between device manufacturers, contract production teams, and research institutes is accelerating technology validation and fostering nimble responses to evolving regulatory pathways.

Tariff Impact: Navigating 2025 U.S. Trade Policy

New U.S. tariffs slated for 2025 prompt IVUS manufacturers to reconsider sourcing methods, pursue nearshoring, and activate contingency strategies that counter anticipated cost pressures. Hospitals and outpatient centers are responding by renegotiating supply contracts and prioritizing bundled procurement, ensuring resource optimization amid uncertain pricing environments. Flexible supply chains and proactive risk mitigation are proving essential for maintaining competitive pricing and adapting to policy changes.

Methodology & Data Sources

This report integrates qualitative interviews with cardiologists, imaging specialists, and healthcare executives. All findings reflect analysis of peer-reviewed literature, recent regulatory guidance, and cross-referencing of industry benchmarks and leading global conference discussions.

Why This Report Matters to Executives

• Gain actionable insights into evolving IVUS technologies, clinical frameworks, and shifting market competition—enabling sound investment and strategic planning.
• Benchmark sector leaders’ product and business models, empowering your organization to identify opportunities in mature and emerging markets, and shape sustainable growth strategies.
• Unlock new pathways for growth by leveraging digital health integration and adaptive procurement tactics, expanding clinical reach and operational agility.

Conclusion

As clinical requirements, technologies, and regulations shift, the intravascular ultrasound market continues its transition. This report delivers the critical analysis leaders need for informed decisions and organizational resilience within a dynamic healthcare sector.

Additional Product Information:

• Purchase of this report includes 1 year online access with quarterly updates.
• This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.